Endocarditis enterococcal Basic Information

Epidemiology

Enterococcal endocarditis represents a significant portion of heart infections worldwide. Enterococcus species account for approximately 10 to 15 percent of all cases of infective endocarditis, which is an infection of the heart's inner lining and valves.12 Among enterococcal infections, Enterococcus faecalis emerges as the dominant culprit, responsible for about 90 percent of enterococcal endocarditis cases.2 This makes it one of the main causes of infective endocarditis globally.3

The disease shows clear demographic patterns. It affects men more frequently than women, with male patients representing approximately 78 percent of cases in some studies.2 The median age of patients diagnosed with enterococcal endocarditis is around 72 years, with most patients falling between 60 and 79 years of age.2 This demographic skew reflects the reality that enterococcal endocarditis generally affects an elderly and fragile population.3

The type of valve affected also varies. Most cases involve native heart valves, accounting for about 61 percent of infections.2 Elderly patients with cardiac implantable electronic devices and younger patients with a history of intravenous drug use show higher incidence rates of infective endocarditis overall.1

Causes

Enterococcus bacteria naturally inhabit the human body, particularly residing in the gastrointestinal tract as a commensal member of the common vertebrate microbiome.1 These bacteria possess remarkable abilities to withstand a broad range of environmental conditions including varying pH levels, temperatures, salinity, and bile acids, which allows them to thrive in diverse locations within the body.1

The infection begins when these bacteria enter the bloodstream, a process that can occur through various routes. Medical or dental procedures that break the skin or other tissues provide opportunities for bacteria to access the blood.4 Once in the bloodstream, the bacteria travel to the heart and can settle on the inner lining of the heart chambers or on the heart valves themselves.

Research demonstrates that Enterococcus faecalis possesses a unique capacity to colonize the undamaged cardiovascular endothelial surface directly and produce robust microcolony biofilms, which are communities of bacteria encapsulated within a protective matrix.1 This ability challenges the traditional belief that heart valve infection requires pre-existing tissue damage. The bacteria can attach to healthy tissue through initial biofilm formation, which plays a crucial regulatory role in infections.1

Risk Factors

Several factors significantly increase the risk of developing enterococcal endocarditis. Individuals with structural abnormalities of the heart face elevated risk, particularly those with damaged or artificial heart valves, congenital heart defects, or previous episodes of endocarditis.56 Heart conditions such as rheumatic valve disease, bicuspid aortic valves, calcific aortic valves, mitral valve prolapse, and hypertrophic cardiomyopathy all predispose individuals to infection.7

Prosthetic heart valves and other intracardiac devices represent a particular risk, as these artificial materials provide surfaces where bacteria can more easily attach and form colonies.56 Patients with pacemakers or implantable cardioverter defibrillators also face increased vulnerability.6

Medical interventions and healthcare settings contribute to risk as well. Intravenous drug use dramatically increases the likelihood of developing endocarditis, as contaminated needles introduce bacteria directly into the bloodstream.6 Hemodialysis for kidney failure, recent vascular catheterization, hospitalization, and extra-cardiac surgical procedures all create opportunities for bacterial entry into the blood.8 Long-term indwelling catheters, particularly those used for chemotherapy delivery, also present risk.9

Other significant risk factors include diabetes, conditions affecting the immune system such as HIV and AIDS, poor dental health and gum disease, and infections elsewhere in the body.69 Previous bacterial endocarditis substantially increases the risk of recurrent infection.6 Advanced age itself serves as a risk factor, with enterococcal endocarditis predominantly affecting older adults.3

Symptoms

The symptoms of enterococcal endocarditis can vary considerably from person to person, and the disease may develop either suddenly with severe manifestations or gradually over time. Common symptoms frequently resemble flu-like illness, making early recognition challenging.55

Fever represents one of the most frequent symptoms, often presenting as a temperature above 100 degrees Fahrenheit (38.4 degrees Celsius).5 Patients commonly experience chills and night sweats that can be quite drenching. Fatigue and a general feeling of unwellness pervade daily activities, making even simple tasks feel exhausting.5

Heart-related symptoms include chest pain, particularly when breathing, and shortness of breath that may worsen with physical activity.55 A new heart murmur or a change in an existing murmur may occur as the infection damages heart valves, creating abnormal blood flow patterns that produce whooshing sounds.5 The heart may beat faster than normal, a condition called tachycardia.9

Musculoskeletal complaints are common, with patients reporting aching joints and muscles throughout the body.55 Swelling may develop in the feet, legs, or abdomen as the heart struggles to pump blood efficiently.5 Loss of appetite leads to unexplained weight loss over time.5

Less common but distinctive symptoms include blood appearing in the urine, which may make it look pink, red, or cola-colored.55 Tenderness may develop under the left rib cage where the spleen is located.5 Some patients develop characteristic skin findings, including painless red, purple, or brown flat spots on the palms of the hands or soles of the feet called Janeway lesions, painful red or purple bumps on the fingertips or toes known as Osler nodes, or tiny purple, red, or brown spots on the skin, in the whites of the eyes, or inside the mouth called petechiae.55

Prevention

Preventing enterococcal endocarditis requires attention to multiple aspects of health maintenance, particularly for individuals at elevated risk. Maintaining excellent dental hygiene stands as a cornerstone of prevention, as bacteria from the mouth can enter the bloodstream during routine activities like chewing and tooth brushing, especially when gum disease is present.6

Individuals with heart conditions that place them at increased risk should be vigilant about any procedures that might introduce bacteria into the bloodstream. This includes informing all healthcare providers, including dentists, about their heart condition before any medical or dental procedures. Some patients may require preventive antibiotics before certain dental or medical procedures, though specific recommendations have evolved over time.

For those who use intravenous drugs, the risk of endocarditis is dramatically elevated. Avoiding injection drug use or seeking treatment programs represents critical prevention. When intravenous medications are medically necessary, ensuring sterile technique and proper catheter care becomes essential.9

Prompt attention to any infections elsewhere in the body helps prevent bacteria from spreading through the bloodstream to the heart. This includes treating skin infections, urinary tract infections, and respiratory infections without delay. Regular medical check-ups allow for early detection and management of risk factors like diabetes and immune system disorders.6

Individuals with prosthetic heart valves, pacemakers, or other cardiac devices require particularly careful monitoring and should be alert to any signs of infection. Understanding personal risk factors and maintaining open communication with healthcare providers enables appropriate preventive strategies tailored to individual circumstances.

Pathophysiology

The development of enterococcal endocarditis involves complex biological processes that transform normal heart tissue into an infected, damaged structure. When Enterococcus bacteria enter the bloodstream, they travel to the heart seeking sites where they can attach and multiply. The bacteria show a particular affinity for areas where the endocardium, the inner lining of the heart, has been damaged or where artificial materials like prosthetic valves provide attachment surfaces.1

The initial attachment process involves the bacteria adhering to the endothelial surface and forming biofilms, which are structured communities of bacteria surrounded by a protective matrix they produce themselves.1 These biofilms create robust microcolonies that become encapsulated, making them remarkably resistant to both the body's immune defenses and antibiotic treatments. The ability of Enterococcus faecalis to colonize even undamaged endothelial surfaces distinguishes it from many other organisms.1

As the infection progresses, the bacteria continue multiplying and form structures called vegetations, which are clumps made up of the infecting organisms, fibrin (a protein involved in blood clotting), platelets (tiny cell fragments in the blood), and other blood components.6 These vegetations can grow quite large and become friable, meaning they break apart easily.

The bacteria within these vegetations produce enzymes and toxins that actively destroy the surrounding heart tissue.1 This destruction prevents normal healing and progressively damages the heart valves. As valves become damaged, they may not close properly, leading to valvular regurgitation where blood leaks backward through the valve, or they may become obstructed, preventing normal blood flow.6

The infection can extend beyond the valve tissue into the heart muscle itself, sometimes forming abscesses, which are pockets of pus and infected tissue.7 The damaged heart must work harder to pump blood effectively. When the heart cannot compensate for the valve damage and increased workload, heart failure may develop.5

Pieces of the vegetations can break off and travel through the bloodstream as emboli, blocking blood vessels in distant organs and causing complications such as stroke, kidney damage, lung problems, or tissue damage in the fingers and toes.9 The ongoing infection also triggers systemic inflammatory responses throughout the body, contributing to symptoms like fever, fatigue, and muscle aches.

Enterococci demonstrate particular resilience because they possess natural resistance to many commonly used antibiotics. They have low-affinity penicillin-binding proteins, which means penicillin and related antibiotics don't bind as effectively to their targets, making the bacteria partially resistant to these medications.3 They also show high-level resistance to most cephalosporins and sometimes carbapenems, significantly limiting treatment options.3